Vitro Biopharma, Inc. Quarterly Operating Margin in % from Q3 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2022 to Q2 2024.
  • Vitro Biopharma, Inc. Operating Margin for the quarter ending July 31, 2024 was -481 %, a 33.4% decline year-over-year.
  • Vitro Biopharma, Inc. annual Operating Margin for 2015 was -203 %, a 42.3% decline from 2014.
  • Vitro Biopharma, Inc. annual Operating Margin for 2014 was -143 %, a 78.3% increase from 2013.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -481 -121 -33.4% May 1, 2024 Jul 31, 2024
Q1 2024 -412 +24.9 +5.69% Feb 1, 2024 Apr 30, 2024
Q4 2023 -494 -219 -79.5% Nov 1, 2023 Jan 31, 2024
Q3 2023 -305 -124 -68.5% Aug 1, 2023 Oct 31, 2023
Q2 2023 -361 May 1, 2023 Jul 31, 2023
Q1 2023 -437 Feb 1, 2023 Apr 30, 2023
Q4 2022 -275 Nov 1, 2022 Jan 31, 2023
Q3 2022 -181 Aug 1, 2022 Oct 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.